Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-52.05	51.92	108.27
Graham Fair Price	41.36	79.72	56.40
PEG	99.55	< 0.005	-0.80
Price/Book	-16.63	0.45	0.54
Price/Cash Flow	49.26	-13.63	-26.86
Prices/Earnings	58.32	-0.36	-0.86
Price/Sales	-51.06	6.81	13.91
Price/FCF	49.26	-13.63	-26.86
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-14.39	0.66	0.77
Operating Margin	17.40	0.61	0.52
ROA	-100.00	-0.11	-0.06
ROE	-0.16	-0.31	-100.00
ROIC	< 0.005	0.02	100.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.00	0.02	inf
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-0.50	1.00	99.59
EPS QOQ	-0.01	-1.00	-9200.21
FCF QOQ	-17.29	-0.64	96.28
Revenue QOQ	-0.54	0.70	31.22
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	< 0.005	-60.37
Days Sales Outstanding (DSO)	66.41	116.23	75.00
Inventory Turnover	4568000.00	11527000.00	152.34
Debt/Capitalization	0.63	0.63	< 0.005
Quick Ratio	0.09	0.21	139.31
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	30.04	30.02	-0.04
Cash	0.69	1.14	65.73
Capex	-0.46	-0.83	-80.55
Free Cash Flow	-0.60	-0.99	-64.23
Revenue	1.16	1.98	70.29
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.13	0.13	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	81.57	40.78	-50.00
Naive Interpretation	Member

06 - Financial Health · Bad

Rating